Aktuelle Ernährungsmedizin 2025; 50(03): 179-194
DOI: 10.1055/a-2500-0568
CME-Fortbildung

Darmversagen

Short bowel syndrome
Georg Lamprecht
,
Robert H. Förster
Preview

Der langstreckige Verlust von Dünndarm ist mit dem Leben nicht vereinbar. Aber mit der langfristigen parenteralen Ernährung steht ein wirksames, komplikationsarmes und mit guter Lebensqualität verbundenes Organersatzverfahren zur Verfügung – vergleichbar mit der Dialyse beim Nierenversagen. Die Zusammensetzung der parenteralen Substitution muss individuell für jeden Patienten festgelegt werden. Die Pathophysiologie des Darmversagens und die funktionelle Anatomie des Patienten stellen hierfür die Basis dar.

Abstract

Intestinal failure is defined as the reduction of gut function below the minimum necessary for the absorption of macronutrients and/or water and electrolytes, such that intravenous supplementation is required to maintain health and/or growth. Intestinal insufficiency is the corresponding condition that can be compensated by diet, supplements and medication. Short bowel following extensive small intestinal resection is the most common cause of intestinal failure. Parenteral nutrition is the effective organ replacement therapy for intestinal failure, associated with few complications and good quality of life. Parenteral supplementation should be individualized and be put together based on the individual remaining absorptive capacity of the intestine and the intestinal losses which are mainly a function of the functional anatomy – short bowel – jejunostomy (SB-J), SB – jejunocolonic anastomosis (SB-JC) or SB – jejuno-ileolcolonic anastomosis (SB-JIC). Because of the functional importance of the colon SB-JC and SB-JIC are recently often summarized as SB – colon-in continuity (SB-CiC). Central venous access is the Achillesʼ heel of parenteral nutrition. Tunneled single-lumen catheters (Broviac or Hickman) are the catheters of choice. Taurolidine-containing catheter lock solutions reduce the risk of catheter-related infections. Pharmacological therapy includes antisecretory, motility-inhibiting, and trophic strategies, as well as bile acid binding in cases of resected terminal ileum. Reconstructive surgery (usually reanastomosis of distal, disconected bowel segments) should be planned 6–12 months after the last operation, once postoperative conditions and the patient's overall health have stabilized.



Publication History

Article published online:
06 June 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany